Balance Labs, Inc. BLNC
$1.55
-$0.02-1.27%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 7,116.45% | 6,919.40% | 6,835.83% | 114.53% | 57.93% |
| Gross Profit | -7,092.28% | -6,899.00% | -6,832.60% | -114.53% | -57.93% |
| SG&A Expenses | 116.03% | 151.27% | 155.33% | 79.50% | 175.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4,472.33% | 4,665.68% | 4,732.88% | 104.63% | 88.18% |
| Operating Income | -4,457.29% | -4,652.07% | -4,730.67% | -104.63% | -88.18% |
| Income Before Tax | -6,741.21% | -7,463.24% | -5,915.58% | -616.78% | -11.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6,741.21% | -7,463.24% | -5,915.58% | -616.78% | -11.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6,741.21% | -7,463.24% | -5,915.58% | -616.78% | -11.54% |
| EBIT | -4,457.29% | -4,652.07% | -4,730.67% | -104.63% | -88.18% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -4,177.93% | -4,654.17% | -3,673.25% | -608.87% | -11.52% |
| Normalized Basic EPS | -1,867.74% | -1,927.52% | -1,964.14% | -787.40% | -38.39% |
| EPS Diluted | -4,177.93% | -4,654.17% | -3,673.25% | -546.32% | 0.93% |
| Normalized Diluted EPS | -1,946.98% | -2,012.59% | -1,960.00% | -782.68% | -33.04% |
| Average Basic Shares Outstanding | 76.76% | 47.72% | 18.68% | 0.38% | 0.00% |
| Average Diluted Shares Outstanding | 68.53% | 40.85% | 23.61% | 5.31% | 4.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |